Lung Cancer Screening

The Surgical Clinics of North America
Mark E Deffebach, Linda Humphrey

Abstract

Screening for lung cancer in high-risk individuals with annual low-dose computed tomography has been shown to reduce lung cancer mortality by 20% and is recommended by multiple health care organizations. Lung cancer screening is not a specific test; it is a process that involves appropriate selection of high-risk individuals, careful interpretation and follow-up of imaging, and annual testing. Screening should be performed in the context of a multidisciplinary program experienced in the diagnosis and management of lung nodules and early-stage lung cancer.

References

Jan 1, 1986·Journal of Chronic Diseases·G D FriedmanB H Fireman
Aug 17, 2000·Journal of the National Cancer Institute·P M MarcusP C Prorok
Feb 26, 2003·Radiology·Stephen J SwensenMedy A Clemens
May 6, 2004·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Jun 8, 2006·Journal of the National Cancer Institute·Pamela M MarcusRobert S Fontana
Sep 23, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Dong Ming XuRob van Klaveren
Oct 27, 2006·The New England Journal of Medicine·UNKNOWN International Early Lung Cancer Action Program InvestigatorsOlli S Miettinen
Dec 4, 2009·The New England Journal of Medicine·Rob J van KlaverenHarry J de Koning
May 22, 2010·AJR. American Journal of Roentgenology·Dianna D CodyXizeng Wu
Oct 13, 2010·Journal of the National Cancer Institute·Donald E HensonArnold M Schwartz
Nov 4, 2010·Radiology·UNKNOWN National Lung Screening Trial Research TeamCarl J Zylak
Jul 1, 2011·The New England Journal of Medicine·UNKNOWN National Lung Screening Trial Research TeamJoRean D Sicks
Oct 7, 2011·The British Journal of Radiology·M MascalchiE Paci
Oct 28, 2011·JAMA : the Journal of the American Medical Association·Martin M OkenUNKNOWN PLCO Project Team
Jan 15, 2013·CA: a Cancer Journal for Clinicians·Richard WenderRobert A Smith
Jan 26, 2013·American Journal of Respiratory and Critical Care Medicine·Nanda HorewegHarry J de Koning
Feb 22, 2013·The New England Journal of Medicine·Martin C TammemägiChristine D Berg
May 18, 2013·The European Respiratory Journal·Maurizio InfanteMatthijs Oudkerk
Jul 13, 2013·The European Respiratory Journal·Nanda HorewegHarry J de Koning
Jul 19, 2013·The New England Journal of Medicine·Stephanie A KovalchikHormuzd A Katki
Sep 6, 2013·The New England Journal of Medicine·Denise R AberleUNKNOWN National Lung Screening Trial Research Team
Dec 3, 2013·The European Respiratory Journal·Marie-Pierre Revel
Dec 11, 2013·JAMA Internal Medicine·Edward F PatzUNKNOWN NLST Overdiagnosis Manuscript Writing Team
Dec 11, 2013·JAMA Internal Medicine·Russell P HarrisNoel T Brewer
Jan 1, 2014·Annals of Internal Medicine·Virginia A Moyer, UNKNOWN U.S. Preventive Services Task Force
Feb 5, 2014·Annals of Internal Medicine·John BrodersenBruno Heleno
Mar 25, 2014·Annals of Internal Medicine·John BrodersenJesper Holst Pedersen
Apr 25, 2014·Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes·Daria ManosJohn R Mayo
May 30, 2014·Journal of the National Cancer Institute·Martin C TammemägiKathryn L Taylor
Jun 13, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Giulia VeronesiMassimo Bellomi
Jun 13, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Christopher G SlatoreLinda L Humphrey
Sep 2, 2014·Journal of the American College of Radiology : JACR·Brady J McKeeChristoph Wald
Nov 6, 2014·The New England Journal of Medicine·William C BlackUNKNOWN National Lung Screening Trial Research Team
Dec 3, 2014·Journal of the American College of Radiology : JACR·Ella A KazerooniPamela A Wilcox

❮ Previous
Next ❯

Citations

Jun 10, 2016·World Journal of Surgical Oncology·Mohannad Al-TarakjiIsidoro Di Carlo
Nov 17, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yanding ZhaoChao Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Vivek Verma, Weining Zhen
International Journal of Clinical Oncology
Tatsuo OhiraHarubumi Kato
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sashendra Senthi, Suresh Senan
© 2021 Meta ULC. All rights reserved